恩格列净在沙特阿拉伯2型糖尿病患者中的安全性:一项批准后的安全性研究

{"title":"恩格列净在沙特阿拉伯2型糖尿病患者中的安全性:一项批准后的安全性研究","authors":"Saud Alsifri, Abdulrahman M. Almaghamsi, A. S. Mahfouz, W. Shehab-Eldin, S. Rakha, Emad R. Issak","doi":"10.4236/ijcm.2023.143010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":58771,"journal":{"name":"临床医学国际期刊(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study\",\"authors\":\"Saud Alsifri, Abdulrahman M. Almaghamsi, A. S. Mahfouz, W. Shehab-Eldin, S. Rakha, Emad R. Issak\",\"doi\":\"10.4236/ijcm.2023.143010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":58771,\"journal\":{\"name\":\"临床医学国际期刊(英文)\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"临床医学国际期刊(英文)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4236/ijcm.2023.143010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"临床医学国际期刊(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/ijcm.2023.143010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}